Latham, Links advise on Malaysia's largest IPO in 2 years
Latham & Watkins and Mah-Kamariyah & Philip Koh have advised Malaysian palm oil company Johor Plantations Group on its 735-million-ringgit ($157 million) initial public offering, the country's biggest in more than two years.
Linklaters and Christopher & Lee Ong, Rajah & Tann’s Malaysia…
A&O Shearman, CC, AZP, AHP guide Indonesia’s $2.35 bln global sukuk issue
Global law firms Clifford Chance and A&O Shearman and local law firms AZP Legal Consultants and Assegaf Hamzah & Partners (AHP) have advised on the issuance of Indonesia’s landmark $2.35 billion global sukuk.
JSA, IndusLaw, A&O Shearman act on $401mln IndiGo divesture
J. Sagar Associates has advised Interglobe Enterprises on a 2 percent divesture in low-cost Indian airline IndiGo for 33.6 billion rupees ($401 million). Citigroup, which bought IndiGo shares worth 13.6 billion rupees via the open market, was advised by IndusLaw and A&O Shearman.
India: Resolut, Khaitan guide investors in $665mln Zepto funding
Resolut Partners and Khaitan & Co have guided lead investor Glade Brook Capital Partners and co-investor Lightspeed, respectively, on a $665 million investment into Indian e-commerce company Zepto.
White & Case guides $380mln U.S.-Japan LNG deal
Global law firm White & Case has advised Japan Petroleum Exploration Co. (JAPEX) on the acquisition through its U.S. subsidiary of an equity interest in Gulf Coast LNG Holdings, which owns an interest in the Freeport LNG project in Texas, from JERA Americas for approximately $380 million.
CC acts on $870 mln HK telecom infra deal
Magic Circle law firm Clifford Chance has advised China Merchants Capital (CMC) on its $870 million investment for a 40 percent stake in the fibre assets of HKT Trust & HK, a subsidiary of Hong Kong telecom group PCCW.
Reed Smith, Freshfields, Kirkland on Henlius’ $691 mln take-private deal
Freshfields Bruckhaus Deringer is representing Hong Kong-listed biotech company Henlius on its $691 million take-private deal offer from Shanghai Fosun New Medicine Research Company, which is being advised by Reed Smith.
Cleary, Goodwin advise on Takeda’s $6 bln drug deal
Cleary Gottlieb Steen & Hamilton has advised Japanese pharmaceutical giant Takeda on its planned acquisition of U.S.-based Nimbus Therapeutics' experimental psoriasis drug, with Goodwin Procter acting for the seller.
CC, Links lead on Sunshine Insurance’s $861 mln HK IPO
Clifford Chance has advised Beijing-based Sunshine Insurance Group on its HK$6.7 billion ($861 million) IPO on the Hong Kong Stock Exchange, with Linklaters and King & Wood Mallesons acting for the underwriters.
Latham, Skadden lead on Vietnamese EV maker’s Nasdaq IPO
Latham & Watkins, YKVN, and Rajah & Tann Singapore have advised Vietnamese EV maker VinFast on its planned IPO on the Nasdaq, with Skadden, Arps, Slate, Meagher & Flom and VILAF representing the underwriters.